[Federal Register Volume 84, Number 61 (Friday, March 29, 2019)]
[Notices]
[Page 11977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06088]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, is limited only by room seating available, (120). The public is
also welcome to listen to the meeting via teleconference at 888-455-
9748, passcode: 4373458; 100 teleconference lines are available. Time
will be available for public comment. The public is welcome to submit
written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt of written public comment is May 2, 2019. All
requests must contain the name, address, and organizational affiliation
of the speaker, as well as the topic being addressed. Written comments
should not exceed one single-spaced typed page in length and delivered
in 3 minutes or less. Members of the public who wish to provide public
comments should plan to attend the public comment session at the start
time listed. Please note that the public comment period may end before
the time indicated, following the last call for comments. Written
comments received in advance of the meeting will be included in the
official record of the meeting. Registration is required to attend in
person or on the phone. Interested parties must be processed in
accordance with established federal policies and procedures and may
register at https://www.cdc.gov/hicpac/.
DATES: The meeting will be held on May 16, 2019, 9:00 a.m. to 5:00
p.m., EDT, and May 17, 2019, 9:00 a.m. to 12:00 p.m., EDT.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE,
Atlanta, Georgia 30329-4027 and teleconference at 888-455-9748,
passcode: 4373458.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027 Telephone (404)
498-0730. Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: The
Healthcare Personnel Guideline Workgroup and the Neonatal Intensive
Care Unit (NICU) Guideline Workgroup. The agenda also includes updates
on CDC and DHQP activities. Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06088 Filed 3-28-19; 8:45 am]
BILLING CODE 4163-19-P